Said El Shamieh: VEGFA Genetic Variants and Bleeding Risk During Warfarin Therapy
Said El Shamieh, Associate Editor at BMC Medical Genomics (Springer Nature) and Frontiers in Bioscience-Landmark, Professor at Beirut Arab University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Pharmacogenomics and Personalized Medicine, adding:
“VEGFA and Warfarin PGx
Here, we asked whether genetic variants in VEGFA, a gene involved in vascular integrity and endothelial repair, might contribute to bleeding risk during warfarin therapy.
In a cohort of Saudi patients, significant associations were found between VEGFA genotypes and bleeding. Though exploratory and requiring validation in larger cohorts, these results suggest that bleeding susceptibility during anticoagulation may involve additional pathways beyond the canonical ones.
Grateful for the collaboration with Pr. Hana Fakhoury Hajeer, Ms. Yasmine Holail, and colleagues.”
Title: Five VEGFA Polymorphisms and Bleeding During Warfarin Therapy in a Saudi Population: An Exploratory Retrospective Cohort Study
Authors: Jasmine Holail, Reem Mobarak, Bandar Al-Ghamdi, Said El Shamieh, Hani Tamim, Ziad Ahmad Kanaan, Hana MA Fakhoury, Khaled Alkattan
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems
-
Sep 20, 2026, 01:15Thierry Fumeaux: From Efficacy to Effectiveness – The Value of Real-World Evidence
-
Sep 20, 2026, 01:04Omar Danoun: Levetiracetam May Increase Thromboembolic Risk With DOACs
-
Sep 20, 2026, 01:02Mohamed Abo-Aly: Which Antiseizure Medication is Safest for Patients on DOACs?
-
Sep 20, 2026, 00:58Hamza Rafiq: How Does a Deep Vein Thrombosis Become a PE?
-
Sep 20, 2026, 00:50A Shared Platelet Factor 4–Targeted Immune Mechanism in Adenovirus Infection – NEJM
-
Sep 20, 2026, 00:46Julia R. Coleman: Platelet Biology and Sex Differences in the Plasma Milieu at AAST 2026
-
Sep 19, 2026, 18:03Manisha Madkaikar: Clinical, Hematological, and Molecular Features of Sickle β-Thalassemia